Keating Active ETF Volume Surges 12× as Talos Jumps

Keating Active ETF (KEAT) has seen unusual trading volume, which is 12× higher than its average daily volume.

Within Keating Active ETF, GlaxoSmithKline, a 4.0% weight, slipped despite the company highlighting promising early trial results for its experimental cancer drug Morez and outlining ambitious long‑term oncology‑driven sales goals. Talos Energy, also a 4.0% holding, drew attention after KeyCorp sharply raised its earnings forecasts and lifted its price target from $15 to $21 with an Overweight rating, helping fuel a strong move in the shares. Verizon Communications, at 3.3% of the portfolio, was in focus as KeyBanc reiterated a Hold rating with the stock trading near its 52‑week high, while the broader analyst consensus still points to modest upside from current levels.